478 related articles for article (PubMed ID: 29283413)
1. Impact of the Oral Adsorbent AST-120 on Organ-Specific Accumulation of Uremic Toxins: LC-MS/MS and MS Imaging Techniques.
Sato E; Saigusa D; Mishima E; Uchida T; Miura D; Morikawa-Ichinose T; Kisu K; Sekimoto A; Saito R; Oe Y; Matsumoto Y; Tomioka Y; Mori T; Takahashi N; Sato H; Abe T; Niwa T; Ito S
Toxins (Basel); 2017 Dec; 10(1):. PubMed ID: 29283413
[TBL] [Abstract][Full Text] [Related]
2. Impacts of Indoxyl Sulfate and p-Cresol Sulfate on Chronic Kidney Disease and Mitigating Effects of AST-120.
Liu WC; Tomino Y; Lu KC
Toxins (Basel); 2018 Sep; 10(9):. PubMed ID: 30208594
[TBL] [Abstract][Full Text] [Related]
3. Metabolomic search for uremic toxins as indicators of the effect of an oral sorbent AST-120 by liquid chromatography/tandem mass spectrometry.
Kikuchi K; Itoh Y; Tateoka R; Ezawa A; Murakami K; Niwa T
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Nov; 878(29):2997-3002. PubMed ID: 20870466
[TBL] [Abstract][Full Text] [Related]
4. Protein-bound uremic toxins: new culprits of cardiovascular events in chronic kidney disease patients.
Ito S; Yoshida M
Toxins (Basel); 2014 Feb; 6(2):665-78. PubMed ID: 24561478
[TBL] [Abstract][Full Text] [Related]
5. Exploring binding characteristics and the related competition of different protein-bound uremic toxins.
Deltombe O; de Loor H; Glorieux G; Dhondt A; Van Biesen W; Meijers B; Eloot S
Biochimie; 2017 Aug; 139():20-26. PubMed ID: 28528271
[TBL] [Abstract][Full Text] [Related]
6. Improved dialysis removal of protein-bound uremic toxins by salvianolic acids.
Li J; Wang Y; Xu X; Cao W; Shen Z; Wang N; Leng J; Zou N; Shang E; Zhu Z; Guo J; Duan J
Phytomedicine; 2019 Apr; 57():166-173. PubMed ID: 30772752
[TBL] [Abstract][Full Text] [Related]
7. Molecular and Cellular Mechanisms that Induce Arterial Calcification by Indoxyl Sulfate and P-Cresyl Sulfate.
Opdebeeck B; D'Haese PC; Verhulst A
Toxins (Basel); 2020 Jan; 12(1):. PubMed ID: 31963891
[TBL] [Abstract][Full Text] [Related]
8. Effects of the oral adsorbent AST-120 on fecal p-cresol and indole levels and on the gut microbiota composition.
Sato E; Hosomi K; Sekimoto A; Mishima E; Oe Y; Saigusa D; Ito S; Abe T; Sato H; Kunisawa J; Niwa T; Takahashi N
Biochem Biophys Res Commun; 2020 May; 525(3):773-779. PubMed ID: 32147096
[TBL] [Abstract][Full Text] [Related]
9. Protein-bound uremic toxins, inflammation and oxidative stress: a cross-sectional study in stage 3-4 chronic kidney disease.
Rossi M; Campbell KL; Johnson DW; Stanton T; Vesey DA; Coombes JS; Weston KS; Hawley CM; McWhinney BC; Ungerer JP; Isbel N
Arch Med Res; 2014 May; 45(4):309-17. PubMed ID: 24751327
[TBL] [Abstract][Full Text] [Related]
10. Effects of AST-120 on blood concentrations of protein-bound uremic toxins and biomarkers of cardiovascular risk in chronic dialysis patients.
Lee CT; Hsu CY; Tain YL; Ng HY; Cheng BC; Yang CC; Wu CH; Chiou TT; Lee YT; Liao SC
Blood Purif; 2014; 37(1):76-83. PubMed ID: 24576840
[TBL] [Abstract][Full Text] [Related]
11. Protein-Bound Uremic Toxins and Immunity.
Rocchetti MT; Cosola C; Ranieri E; Gesualdo L
Methods Mol Biol; 2021; 2325():215-227. PubMed ID: 34053061
[TBL] [Abstract][Full Text] [Related]
12. Adsorption of Protein-Bound Uremic Toxins Through Direct Hemoperfusion With Hexadecyl-Immobilized Cellulose Beads in Patients Undergoing Hemodialysis.
Yamamoto S; Sato M; Sato Y; Wakamatsu T; Takahashi Y; Iguchi A; Omori K; Suzuki Y; Ei I; Kaneko Y; Goto S; Kazama JJ; Gejyo F; Narita I
Artif Organs; 2018 Jan; 42(1):88-93. PubMed ID: 28703401
[TBL] [Abstract][Full Text] [Related]
13. The Effect of Sevelamer on Serum Levels of Gut-Derived Uremic Toxins: Results from In Vitro Experiments and A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
Bennis Y; Cluet Y; Titeca-Beauport D; El Esper N; Ureña P; Bodeau S; Combe C; Dussol B; Fouque D; Choukroun G; Liabeuf S
Toxins (Basel); 2019 May; 11(5):. PubMed ID: 31109001
[TBL] [Abstract][Full Text] [Related]
14. Removal of protein-bound, hydrophobic uremic toxins by a combined fractionated plasma separation and adsorption technique.
Brettschneider F; Tölle M; von der Giet M; Passlick-Deetjen J; Steppan S; Peter M; Jankowski V; Krause A; Kühne S; Zidek W; Jankowski J
Artif Organs; 2013 Apr; 37(4):409-16. PubMed ID: 23330821
[TBL] [Abstract][Full Text] [Related]
15. Effect of AST-120 in Chronic Kidney Disease Treatment: Still a Controversy?
Yamaguchi J; Tanaka T; Inagi R
Nephron; 2017; 135(3):201-206. PubMed ID: 27960172
[TBL] [Abstract][Full Text] [Related]
16. Meta-Analysis of the Associations of p-Cresyl Sulfate (PCS) and Indoxyl Sulfate (IS) with Cardiovascular Events and All-Cause Mortality in Patients with Chronic Renal Failure.
Lin CJ; Wu V; Wu PC; Wu CJ
PLoS One; 2015; 10(7):e0132589. PubMed ID: 26173073
[TBL] [Abstract][Full Text] [Related]
17. [Molecular mechanisms for uremic toxin-induced oxidative tissue damage via a cardiovascular-renal connection].
Watanabe H
Yakugaku Zasshi; 2013; 133(8):889-95. PubMed ID: 23903229
[TBL] [Abstract][Full Text] [Related]
18. SLC22A11 Inserts the Uremic Toxins Indoxyl Sulfate and P-Cresol Sulfate into the Plasma Membrane.
Tust M; Müller JP; Fischer D; Gründemann D
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894870
[TBL] [Abstract][Full Text] [Related]
19. Targeting protein-bound uremic toxins in chronic kidney disease.
Niwa T
Expert Opin Ther Targets; 2013 Nov; 17(11):1287-301. PubMed ID: 23941498
[TBL] [Abstract][Full Text] [Related]
20. Organic anion transporters play an important role in the uptake of p-cresyl sulfate, a uremic toxin, in the kidney.
Miyamoto Y; Watanabe H; Noguchi T; Kotani S; Nakajima M; Kadowaki D; Otagiri M; Maruyama T
Nephrol Dial Transplant; 2011 Aug; 26(8):2498-502. PubMed ID: 21303967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
